.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Julphar
Moodys
Daiichi Sankyo
Chubb
Dow
Cantor Fitzgerald
Cerilliant
Cipla
US Department of Justice

Generated: November 21, 2017

DrugPatentWatch Database Preview

IMIPENEM AND CILASTATIN Drug Profile

« Back to Dashboard

Which patents cover Imipenem And Cilastatin, and what generic Imipenem And Cilastatin alternatives are available?

Imipenem And Cilastatin is a drug marketed by Hospira Inc and Acs Dobfar and is included in three NDAs.

The generic ingredient in IMIPENEM AND CILASTATIN is cilastatin sodium; imipenem. There are sixteen drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the cilastatin sodium; imipenem profile page.

Summary for IMIPENEM AND CILASTATIN

Pharmacology for IMIPENEM AND CILASTATIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira Inc
IMIPENEM AND CILASTATIN
cilastatin sodium; imipenem
POWDER;INTRAVENOUS091007-001Nov 16, 2011APRXNoNo► Subscribe► Subscribe► Subscribe
Acs Dobfar
IMIPENEM AND CILASTATIN
cilastatin sodium; imipenem
POWDER;INTRAVENOUS090577-001Dec 21, 2011APRXNoNo► Subscribe► Subscribe► Subscribe
Hospira Inc
IMIPENEM AND CILASTATIN
cilastatin sodium; imipenem
POWDER;INTRAVENOUS090825-001Nov 16, 2011APRXNoNo► Subscribe► Subscribe► Subscribe
Hospira Inc
IMIPENEM AND CILASTATIN
cilastatin sodium; imipenem
POWDER;INTRAVENOUS090825-002Nov 16, 2011APRXNoNo► Subscribe► Subscribe► Subscribe
Acs Dobfar
IMIPENEM AND CILASTATIN
cilastatin sodium; imipenem
POWDER;INTRAVENOUS090577-002Dec 21, 2011APRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Citi
Cipla
Queensland Health
Mallinckrodt
US Army
Chinese Patent Office
Harvard Business School
Boehringer Ingelheim
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot